Table 3 Data by HBV vaccine response
From: Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco
Control group | HIV-infected group | |||||
|---|---|---|---|---|---|---|
Anti-HBs < 10 | Anti-HBs ≥10 | p-Value | Anti-HBs < 10 | Anti-HBs ≥10 | p-Value | |
(n = 27) | (n = 85) | (n = 35) | (n = 14) | |||
m ± SD | m ± SD | m ± SD | m ± SD | m ± SD | ||
Age (months) | 64 ± 38 | 45 ± 35 | 0.991 | 59 ± 36 | 32 ± 26 | 0.998 |
Female | 56% | 37% | 0.080 | 69% | 50% | 0.223 |
%T cells | 67.5 ± 11.5 | 63.1 ± 9.0 | 0.986 | 75.7 ± 7.8 | 75.6 ± 5.9 | 0.652 |
%CD4+ T cells | 34.1 ± 6.7 | 35.1 ± 7.0 | 0.741 | 23.6 ± 9.0 | 30.4 ± 8.4 | 0.008 |
%CD8+ T cells | 27.4 ± 7.5 | 24.8 ± 7.6 | 0.963 | 46.0 ± 12.6 | 40.1 ± 9.2 | 0.928 |
%B cells | 17.9 ± 9.5 | 21.6 ± 8.5 | 0.029 | 14.0 ± 7.0 | 16.7 ± 7.3 | 0.056 |
%NK cells | 8.9 ± 5.0 | 09.1 ± 5.8 | 0.593 | 06.3 ± 3.1 | 04.3 ± 3.5 | 0.983 |
HAART | NA | NA | NA | 65.71% | 85.71% | 0.185 |
HIV Viral load (log) | NA | NA | NA | 2.4 ± 2.3 | 2.4 ± 2.1 | 0.5 |